Mingfang Xu

902 total citations
39 papers, 427 citations indexed

About

Mingfang Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Mingfang Xu has authored 39 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Mingfang Xu's work include Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Esophageal Cancer Research and Treatment (5 papers). Mingfang Xu is often cited by papers focused on Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Esophageal Cancer Research and Treatment (5 papers). Mingfang Xu collaborates with scholars based in China, United States and Pakistan. Mingfang Xu's co-authors include Xueqin Yang, Xuemei Li, Na Peng, Dong Wang, Qiyu Sun, Li Cheng, Shuang Cao, Yanli Xiong, Yang Han and Haixia Wu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mingfang Xu

34 papers receiving 422 citations

Peers

Mingfang Xu
Toshiaki Ishida Japan
Yvonne Teng Singapore
Jindong Shi China
C. Bernard France
Kimon Tzannis Greece
Ray Wilkinson Australia
Chieh-Lun Hsiao Taiwan
Shang‐Yin Wu Taiwan
Anand Pathak United States
Annette Schmider Germany
Toshiaki Ishida Japan
Mingfang Xu
Citations per year, relative to Mingfang Xu Mingfang Xu (= 1×) peers Toshiaki Ishida

Countries citing papers authored by Mingfang Xu

Since Specialization
Citations

This map shows the geographic impact of Mingfang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfang Xu more than expected).

Fields of papers citing papers by Mingfang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingfang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfang Xu. The network helps show where Mingfang Xu may publish in the future.

Co-authorship network of co-authors of Mingfang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingfang Xu. A scholar is included among the top collaborators of Mingfang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingfang Xu. Mingfang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chan, Qun Yang, Yunsheng Ren, et al.. (2025). Ore genesis of the Erdaodianzi gold deposit in Jilin Province, Northeast China: Constraints from Re–Os isotopes and geochemistry of pyrite. Ore Geology Reviews. 186. 106830–106830.
2.
3.
4.
Xu, Mingfang, Zhiyong Zhu, Shijia Li, et al.. (2025). ESR1-dependent suppression of LCN2 transcription reverses autophagy-linked ferroptosis and enhances sorafenib sensitivity in hepatocellular carcinoma. Journal of Physiology and Biochemistry. 81(2). 299–312. 1 indexed citations
5.
Yu, Lianbo, Lijuan Kang, Songtao Xue, et al.. (2024). 807MO High efficacy and safety of interleukin-6-knockdown CD19-targeted CAR-T cells in relapsed/refractory B-ALL patients. Annals of Oncology. 35. S599–S599. 1 indexed citations
6.
Xiao, He, et al.. (2024). Impact of APOBEC3s on the occurrence, development and prognosis of esophageal squamous cell carcinoma. Future Oncology. 21(1). 117–125. 1 indexed citations
7.
8.
Xu, Mingfang, et al.. (2022). Differences in genetic diversity of <i>Pleuronichthys cornutus</i> in the coastal water of China and Japan based on three mitochondrial markers. Biodiversity Science. 30(5). 21485–21485. 1 indexed citations
9.
Yang, Xueqin, Yi Yang, Dong Wang, et al.. (2021). Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes. Journal of Gastrointestinal Oncology. 13(1). 1–12. 12 indexed citations
10.
Yue, Yujuan, Qiyong Liu, Xiaobo Liu, Haixia Wu, & Mingfang Xu. (2021). Comparative analyses on epidemiological characteristics of dengue fever in Guangdong and Yunnan, China, 2004–2018. BMC Public Health. 21(1). 1389–1389. 17 indexed citations
11.
Yang, Yi, Mingfang Xu, Huan Huang, et al.. (2021). Serum carcinoembryonic antigen elevation in benign lung diseases. Scientific Reports. 11(1). 19044–19044. 25 indexed citations
12.
Xie, Yan, et al.. (2021). Clinicopathological characteristics and survival in lung signet ring cell carcinoma: a population-based study. Bosnian Journal of Basic Medical Sciences. 21(6). 752–759. 8 indexed citations
13.
Xu, Mingfang, Nan Dai, Xueqin Yang, et al.. (2021). Characteristics and prognosis of telangiectatic osteosarcoma: a population-based study using the Surveillance, Epidemiology and End Results (SEER) database. Annals of Translational Medicine. 9(9). 796–796. 4 indexed citations
14.
Yang, Yi, et al.. (2020). Complete response of radioresistant brain metastases from non-small cell lung cancer with temozolomide. Medicine. 99(51). e23592–e23592. 5 indexed citations
15.
Qian, Chengyuan, et al.. (2020). Clinical characteristics and risk of second primary lung cancer after cervical cancer: A population-based study. PLoS ONE. 15(8). e0231807–e0231807. 7 indexed citations
16.
Xu, Mingfang, et al.. (2019). Suppression of oncogenic protein translation via targeting eukaryotic translation initiation factor 4E overcomes chemo-resistance in nasopharyngeal carcinoma. Biochemical and Biophysical Research Communications. 512(4). 902–907. 6 indexed citations
17.
18.
19.
20.
Lu, Da‐Bing, et al.. (1994). Epidemiological studies on Echinochasmus liliputanus infection. I. Parasite infection and distribution in final hosts. 7(4). 285–287. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiaki Ishida Breakdown of academic impact, for papers by Yvonne Teng Breakdown of academic impact, for papers by Jindong Shi Breakdown of academic impact, for papers by C. Bernard Breakdown of academic impact, for papers by Kimon Tzannis Breakdown of academic impact, for papers by Ray Wilkinson Breakdown of academic impact, for papers by Chieh-Lun Hsiao Breakdown of academic impact, for papers by Shang‐Yin Wu Breakdown of academic impact, for papers by Anand Pathak Breakdown of academic impact, for papers by Annette Schmider
Rankless by CCL
2026